Article Listing - Funds flowed back into biotech in 2nd qtr 1999, says new study from Burrill

1ST QTR PROCORDIA RESULTS

18 May 1992

Procordia, the Swedish pharmaceutical and food concern, made net profits for the first quarter of 1992 of 1.1 billion Swedish...

W R GRACE TO SELL ENERGY BUSINESSES

18 May 1992

The US company W R Grace has announced that it is to sell its energy businesses for around $700 million...

CUBA DEVELOPING MENINGITIS VACCINE

18 May 1992

Cuba's Carlos J Finlay Institute in Havana is presently developing a new meningitis vaccine which is expected to be suitable...

INOSITOL & INFANT RESPIRATORY DISTRESS

18 May 1992

The administration of inositol to premature infants suffering from respiratory distress syndrome and who are receiving parenteral nutrition during the...

FORTHCOMING MEETINGS

18 May 1992

The following seminars, organized by Management Forum Ltd, which are of potential interest to the pharmaceutical industry will be held...

LIPID-LOWERING OF BENEFIT IN CANCER?

18 May 1992

US research has suggested that lowering cholesterol levels in the blood, either by decreasing cholesterol availablility or decreasing its intracellular...

FORTHCOMING MEETINGS

18 May 1992

The following industry-related meeting are scheduled to be held in London this month and next:

- Product Liability and Medicines is...

Novel Diabetes treatment

18 May 1992

An interleukin-2 fusion toxin product developed by Seragen has been used to treat eight patients with Type 1 diabetes in...

MERCK AG 1991SALES RISE 12%

18 May 1992

Consolidated drug and chemical sales of Merck AG in Zug, Switzerland, rose 12% in 1991 to 2.18 billion Swiss francs...

PASTEUR-MERIEUX RESUMES IG SALES

18 May 1992

The French vaccines and blood products group, Pasteur-Merieux, is to resume distribution of its three main immunoglobulin products, after receiving...